263 related articles for article (PubMed ID: 15672542)
1. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.
Sultana R; Butterfield DA
Neurochem Res; 2004 Dec; 29(12):2215-20. PubMed ID: 15672542
[TBL] [Abstract][Full Text] [Related]
2. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
3. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain.
Hardas SS; Sultana R; Clark AM; Beckett TL; Szweda LI; Murphy MP; Butterfield DA
Redox Biol; 2013; 1(1):80-5. PubMed ID: 24024140
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of 4-hydroxynonenal by rat Kupffer cells.
Luckey SW; Petersen DR
Arch Biochem Biophys; 2001 May; 389(1):77-83. PubMed ID: 11370675
[TBL] [Abstract][Full Text] [Related]
5. Cellular response to the redox active lipid peroxidation products: induction of glutathione S-transferase P by 4-hydroxy-2-nonenal.
Fukuda A; Nakamura Y; Ohigashi H; Osawa T; Uchida K
Biochem Biophys Res Commun; 1997 Jul; 236(2):505-9. PubMed ID: 9240470
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance associated protein 1 together with glutathione plays a protective role against 4-hydroxy-2-nonenal-induced oxidative stress in bovine aortic endothelial cells.
Takahashi K; Tatsunami R; Sato K; Tampo Y
Biol Pharm Bull; 2012; 35(8):1269-74. PubMed ID: 22863924
[TBL] [Abstract][Full Text] [Related]
7. 4-hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes.
Blanc EM; Keller JN; Fernandez S; Mattson MP
Glia; 1998 Feb; 22(2):149-60. PubMed ID: 9537835
[TBL] [Abstract][Full Text] [Related]
8. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.
Völkel W; Sicilia T; Pähler A; Gsell W; Tatschner T; Jellinger K; Leblhuber F; Riederer P; Lutz WK; Götz ME
Neurochem Int; 2006 Jun; 48(8):679-86. PubMed ID: 16483694
[TBL] [Abstract][Full Text] [Related]
9. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
Butterfield DA; Castegna A; Lauderback CM; Drake J
Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
[TBL] [Abstract][Full Text] [Related]
10. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Butterfield DA
Free Radic Biol Med; 2007 Feb; 42(3):371-84. PubMed ID: 17210450
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
Cenini G; Sultana R; Memo M; Butterfield DA
J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
[TBL] [Abstract][Full Text] [Related]
12. Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity.
Xie C; Lovell MA; Markesbery WR
Free Radic Biol Med; 1998 Nov; 25(8):979-88. PubMed ID: 9840744
[TBL] [Abstract][Full Text] [Related]
13. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.
Butterfield DA; Bader Lange ML; Sultana R
Biochim Biophys Acta; 2010 Aug; 1801(8):924-9. PubMed ID: 20176130
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.
Sayre LM; Zelasko DA; Harris PL; Perry G; Salomon RG; Smith MA
J Neurochem; 1997 May; 68(5):2092-7. PubMed ID: 9109537
[TBL] [Abstract][Full Text] [Related]
15. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.
Calingasan NY; Uchida K; Gibson GE
J Neurochem; 1999 Feb; 72(2):751-6. PubMed ID: 9930749
[TBL] [Abstract][Full Text] [Related]
16. Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1).
Rudd LP; Kabler SL; Morrow CS; Townsend AJ
Chem Biol Interact; 2011 Nov; 194(2-3):113-9. PubMed ID: 21925487
[TBL] [Abstract][Full Text] [Related]
17. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
Singh M; Dang TN; Arseneault M; Ramassamy C
J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
[TBL] [Abstract][Full Text] [Related]
18. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
19. Iron-induced lipid peroxidation in rat liver is accompanied by preferential induction of glutathione S-transferase 8-8 isozyme.
Khan MF; Srivastava SK; Singhal SS; Chaubey M; Awasthi S; Petersen DR; Ansari GA; Awasthi YC
Toxicol Appl Pharmacol; 1995 Mar; 131(1):63-72. PubMed ID: 7878679
[TBL] [Abstract][Full Text] [Related]
20. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R
Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
